Everett Cunningham - Feb 27, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Chief Commercial Officer
Signature
/s/ Everett Cunningham by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/1/2023, 04:25 PM
Previous filing
Feb 28, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +7.68K +41.15% $0.00 26.3K Feb 27, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -7.68K -25% $0.00 23K Feb 27, 2023 Common Stock 7.68K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 26,331 shares, Mr. Cunningham also holds, in the aggregate, an additional 99,211 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023.